{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:47:55Z","timestamp":1786650475756,"version":"build-2736575974"},"reference-count":144,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Thorac Med"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/1817-1737.134016","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T01:29:47Z","timestamp":1402018187000},"page":"26","source":"Crossref","is-referenced-by-count":1,"title":["Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases"],"prefix":"10.4103","volume":"9","author":[{"given":"PaulM.","family":"Hassoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Boueiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1817-1737.134016-1","first-page":"2246","volume-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-2","first-page":"343","volume-title":"Survival in patients with primary pulmonary hypertension.Results from a national prospective registry","author":"D\u2032Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-3","first-page":"719","volume-title":"Primary pulmonary hypertension","author":"Gaine","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/1817-1737.134016-4","first-page":"216","volume-title":"Primary pulmonary hypertension.A national prospective study","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-5","first-page":"69","volume-title":"Pulmonary hypertension: Another light in the dark tunnel.Learning the lesson from cancer","author":"Idrees","year":"2013","journal-title":"Ann Thorac Med","ISSN":"https:\/\/id.crossref.org\/issn\/1817-1737","issn-type":"print"},{"key":"key-10.4103\/1817-1737.134016-6","first-page":"159","volume-title":"Endothelial dysfunction in pulmonary hypertension","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-7","first-page":"1425","volume-title":"Treatment of pulmonary arterial hypertension","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-8","first-page":"307","volume-title":"Autoantibodies in patients with primary pulmonary hypertension: Association with anti-Ku","author":"Isern","year":"1992","journal-title":"Am J Med"},{"key":"key-10.4103\/1817-1737.134016-9","first-page":"1628","volume-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-10","first-page":"893","volume-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","author":"Dorfmu\u0308ller","year":"2007","journal-title":"Hum Pathol"},{"key":"key-10.4103\/1817-1737.134016-11","first-page":"344","volume-title":"Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis","author":"Kawut","year":"2003","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-12","first-page":"3043","volume-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-13","first-page":"151","volume-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-14","first-page":"37","volume-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-15","first-page":"211","volume-title":"Systemic sclerosis: The susceptible host (genetics and environment)","author":"Tan","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.4103\/1817-1737.134016-16","first-page":"202","volume-title":"Scleroderma (systemic sclerosis): Classifi cation, subsets and pathogenesis","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-17","first-page":"239","volume-title":"Scleroderma epidemiology","author":"Mayes","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.4103\/1817-1737.134016-18","first-page":"286","volume-title":"An epidemiological study of scleroderma in the West Midlands","author":"Silman","year":"1988","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-19","first-page":"366","volume-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/1817-1737.134016-20","first-page":"596","volume-title":"A study of the prevalence of systemic sclerosis in Northeast England","author":"Allcock","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/1817-1737.134016-21","first-page":"2246","volume-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-22","first-page":"3792","volume-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-23","first-page":"1088","volume-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1817-1737.134016-24","first-page":"1515","volume-title":"Prevalence of pulmonary hypertension in limited and diffuse scleroderma","author":"Battle","year":"1996","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-25","first-page":"515","volume-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-26","first-page":"639","volume-title":"Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody","author":"Sacks","year":"1996","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-27","first-page":"453","volume-title":"Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival","author":"MacGregor","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/1817-1737.134016-28","first-page":"615","volume-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-29","first-page":"1023","volume-title":"Pulmonary arterial hypertension in France: Results from a national registry","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-30","first-page":"104","volume-title":"An epidemiological study of pulmonary arterial hypertension","author":"Peacock","year":"2007","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-31","first-page":"376","volume-title":"Pulmonary arterial hypertension: Baseline characteristics from the REVEAL Registry","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-32","first-page":"520","volume-title":"Vascular complications of scleroderma","author":"Guiducci","year":"2007","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/1817-1737.134016-33","first-page":"110","volume-title":"Mortality and risk factors of scleroderma renal crisis: A French retrospective study of 50 patients","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1817-1737.134016-34","first-page":"2125","volume-title":"The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)","author":"Wigley","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-35","first-page":"3043","volume-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-36","first-page":"10","volume-title":"Survival in patients with pulmonary arterial hypertension treated with fi rst-line bosentan","author":"McLaughlin","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"key-10.4103\/1817-1737.134016-37","first-page":"1626","volume-title":"Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases","author":"Girgis","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"key-10.4103\/1817-1737.134016-38","first-page":"2098","volume-title":"Age and risk of pulmonary arterial hypertension in scleroderma","author":"Schachna","year":"2003","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-39","first-page":"675","volume-title":"Systemic sclerosis.A vascular perspective","author":"LeRoy","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.4103\/1817-1737.134016-40","first-page":"161","volume-title":"Capillary alterations in scleroderma","author":"Fleischmajer","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/1817-1737.134016-41","first-page":"2550","volume-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-42","first-page":"285","volume-title":"Blood coagulation, fi brinolysis, and markers of endothelial dysfunction in systemic sclerosis","author":"Cerinic","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-43","first-page":"403","volume-title":"Predictors of survival in systemic sclerosis (scleroderma)","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-44","first-page":"1048","volume-title":"Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis","author":"Denton","year":"1995","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-45","first-page":"R11","volume-title":"Angiogenic and angiostatic factors in systemic sclerosis: Increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fi ngertip ulcers","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"key":"key-10.4103\/1817-1737.134016-46","first-page":"1529","volume-title":"Elevated vascular endothelial growth factor in systemic sclerosis","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-47","first-page":"889","volume-title":"Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis","author":"Hebbar","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-48","first-page":"95","volume-title":"Autoantibody to U3 nucleolar ribonucleoprotein (fi brillarin) in patients with systemic sclerosis","author":"Okano","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-49","first-page":"462","volume-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-50","first-page":"1688","volume-title":"Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis","author":"Fritzler","year":"1995","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-51","first-page":"274","volume-title":"Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7","author":"Morse","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-52","first-page":"539","volume-title":"Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35","author":"Grigolo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/1817-1737.134016-53","first-page":"1110","volume-title":"Autoimmunity and pulmonary hypertension: A perspective","author":"Nicolls","year":"2005","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-54","first-page":"765","volume-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension","author":"Tamby","year":"2005","journal-title":"Thorax"},{"key":"key-10.4103\/1817-1737.134016-55","first-page":"1602","volume-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-56","first-page":"799","volume-title":"Antibodies to fi broblasts in idiopathic and scleroderma-associated pulmonary hypertension","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-57","first-page":"1128","volume-title":"Identifi cation of target antigens of antifi broblast antibodies in pulmonary arterial hypertension","author":"Terrier","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-58","first-page":"182","volume-title":"Immunosuppressive therapy in connective tissue diseases associated pulmonary arterial hypertension","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-59","first-page":"737","volume-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/1817-1737.134016-60","first-page":"81","volume-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","author":"International","year":"2000","journal-title":"Nat Genet"},{"key":"key-10.4103\/1817-1737.134016-61","first-page":"33S","volume-title":"Genetic basis of pulmonary arterial hypertension: Current understanding and future directions","author":"Newman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1817-1737.134016-62","first-page":"e127","volume-title":"Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension","author":"Koehler","year":"2004","journal-title":"J Med Genet"},{"key":"key-10.4103\/1817-1737.134016-63","first-page":"596","volume-title":"Genetic aspects of pulmonary arterial hypertension","author":"Morse","year":"2001","journal-title":"Ann Med"},{"key":"key-10.4103\/1817-1737.134016-64","first-page":"325","volume-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-65","first-page":"2379","volume-title":"Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenetic protein receptor 2 mutations","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-66","first-page":"2829","volume-title":"Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases","author":"Tew","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-67","first-page":"92","volume-title":"The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis","author":"Karrer","year":"2005","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/1817-1737.134016-68","first-page":"4002","volume-title":"Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis","author":"Tsuchiya","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-69","first-page":"103","volume-title":"\u2212238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis","author":"Tolusso","year":"2005","journal-title":"Immunol Lett"},{"key":"key-10.4103\/1817-1737.134016-70","first-page":"186","volume-title":"Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population","author":"Kawaguchi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-71","first-page":"81","volume-title":"Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis","author":"Hutyrov\u00e1","year":"2004","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-72","first-page":"1295","volume-title":"Analysis of the 5\u2032 fl anking region of the interleukin 10 gene in patients with systemic sclerosis","author":"Crilly","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/1817-1737.134016-73","first-page":"2585","volume-title":"Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence","author":"Zhou","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-74","first-page":"622","volume-title":"Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension","author":"Wipff","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/1817-1737.134016-75","first-page":"2098","volume-title":"Age and risk of pulmonary arterial hypertension in scleroderma","author":"Schachna","year":"2003","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-76","first-page":"269","volume-title":"Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma","author":"Chang","year":"2006","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-77","first-page":"516","volume-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-78","first-page":"284","volume-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-79","first-page":"187","volume-title":"Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients","author":"Ghanem","year":"2009","journal-title":"Ann Thorac Med","ISSN":"https:\/\/id.crossref.org\/issn\/1817-1737","issn-type":"print"},{"key":"key-10.4103\/1817-1737.134016-80","first-page":"507","volume-title":"Right heart function in scleroderma: Insights from myocardial Doppler tissue imaging","author":"Hsiao","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"key-10.4103\/1817-1737.134016-81","first-page":"118","volume-title":"Right heart function and scleroderma: Insights from tricuspid annular plane systolic excursion","author":"Lee","year":"2007","journal-title":"Echocardiography"},{"key":"key-10.4103\/1817-1737.134016-82","first-page":"1803","volume-title":"Cardiac involvement in systemic sclerosis assessed by tissuedoppler echocardiography during routine care: A controlled study of 100 consecutive patients","author":"Meune","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-83","first-page":"1160","volume-title":"Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-84","first-page":"1485","volume-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1817-1737.134016-85","first-page":"1364","volume-title":"Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension","author":"Forfi","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-86","first-page":"926","volume-title":"Systemic sclerosis associated pulmonary hypertension: Improved survival in the current era","author":"Williams","year":"2006","journal-title":"Heart"},{"key":"key-10.4103\/1817-1737.134016-87","first-page":"13","volume-title":"The right ventricle in pulmonary hypertension","author":"Chin","year":"2005","journal-title":"Coron Artery Dis"},{"key":"key-10.4103\/1817-1737.134016-88","first-page":"1883","volume-title":"Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-89","first-page":"169","volume-title":"Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements","author":"Tei","year":"1997","journal-title":"J Am Soc Echocardiogr"},{"key":"key-10.4103\/1817-1737.134016-90","first-page":"317","volume-title":"Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases","author":"Vonk","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"key-10.4103\/1817-1737.134016-91","first-page":"766","volume-title":"The associations between tricuspid annular plane systolic excursion (TAPSE), ventricular dyssynchrony, and ventricular interaction in heart failure patients","author":"Gupta","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"key-10.4103\/1817-1737.134016-92","first-page":"1034","volume-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","author":"Forfi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-93","first-page":"522","volume-title":"Right ventricular tissue Doppler and strain imaging: Ready for clinical use?","author":"Gondi","year":"2007","journal-title":"Echocardiography"},{"key":"key-10.4103\/1817-1737.134016-94","first-page":"1941","volume-title":"High prevalence of right ventricular systolic dysfunction in early systemic sclerosis","author":"Meune","year":"2004","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-95","first-page":"677","volume-title":"Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis","author":"Steen","year":"1996","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-96","first-page":"2431","volume-title":"Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis","author":"Bezante","year":"2007","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-97","first-page":"1137","volume-title":"Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension","author":"Hagger","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/1817-1737.134016-98","first-page":"1292","volume-title":"Sildenafi l versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study","author":"Wilkins","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-99","first-page":"989","volume-title":"Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-100","first-page":"1477","volume-title":"Survival in primary pulmonary hypertension: The impact of epoprostenol therapy","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-101","first-page":"940","volume-title":"Changes in causes of death in systemic sclerosis, 1972-2002","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1817-1737.134016-102","first-page":"274","volume-title":"An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?","author":"Pope","year":"2008","journal-title":"Lupus"},{"key":"key-10.4103\/1817-1737.134016-103","first-page":"985","volume-title":"Pulmonary hypertension associated with systemic lupus erythematosus","author":"Haas","year":"2004","journal-title":"Bull Acad Natl Med"},{"key":"key-10.4103\/1817-1737.134016-104","first-page":"92","volume-title":"A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease","author":"Sullivan","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1817-1737.134016-105","first-page":"299","volume-title":"Pulmonary arterial hypertension: A rare complication of primary Sj\u00f6gren syndrome: Report of 9 new cases and review of the literature","author":"Launay","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1817-1737.134016-106","first-page":"214","volume-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-107","first-page":"1925","volume-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-108","first-page":"1732","volume-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-109","first-page":"76","volume-title":"The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-110","first-page":"3105","volume-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-111","first-page":"27","volume-title":"Regulatory functions of the vascular endothelium","author":"Vane","year":"1990","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-112","first-page":"296","volume-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-113","first-page":"273","volume-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-114","first-page":"485","volume-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol).Results of a randomized trial","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-115","first-page":"425","volume-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease.A randomized, controlled trial","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-116","first-page":"2244","volume-title":"Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol","author":"Badesch","year":"2009","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-117","first-page":"800","volume-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-118","first-page":"683","volume-title":"Safety and effi cacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicenter, open-label, 12-week trial","author":"Tapson","year":"2006","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-119","first-page":"1195","volume-title":"Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma","author":"Farber","year":"1999","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-120","first-page":"237","volume-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","author":"Palmer","year":"1998","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.134016-121","first-page":"213","volume-title":"Emerging medical therapies for pulmonary arterial hypertension","author":"Gali\u00e8","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"key-10.4103\/1817-1737.134016-122","first-page":"1119","volume-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomized placebo-controlled study","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"key-10.4103\/1817-1737.134016-123","first-page":"896","volume-title":"Bosentan therapy for pulmonary arterial hypertension","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-124","first-page":"1336","volume-title":"Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: A subgroup analysis of the pivotal clinical trials and their open-label extensions","author":"Denton","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1817-1737.134016-125","first-page":"1626","volume-title":"Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases","author":"Girgis","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"key-10.4103\/1817-1737.134016-126","first-page":"1121","volume-title":"Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension","author":"Iannone","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1817-1737.134016-127","first-page":"1487","volume-title":"Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers","author":"Jain","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/1817-1737.134016-128","first-page":"3010","volume-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-129","first-page":"2148","volume-title":"Sildenafi l citrate therapy for pulmonary arterial hypertension","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1817-1737.134016-130","first-page":"2417","volume-title":"Sildenafi l for pulmonary arterial hypertension associated with connective tissue disease","author":"Badesch","year":"2007","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1817-1737.134016-131","first-page":"2894","volume-title":"Tadalafil therapy for pulmonary arterial hypertension","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-132","first-page":"1257","volume-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/1817-1737.134016-133","first-page":"1007","volume-title":"Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension","author":"Hoeper","year":"2004","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-134","first-page":"521","volume-title":"Addition of sildenafi l to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: A randomized trial","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1817-1737.134016-135","first-page":"469","volume-title":"Addition of sildenafi l to bosentan monotherapy in pulmonary arterial hypertension","author":"Mathai","year":"2007","journal-title":"Eur Respir J"},{"key":"key-10.4103\/1817-1737.134016-136","first-page":"580","volume-title":"Primary pulmonary hypertension: Natural history and the importance of thrombosis","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-137","first-page":"1461","volume-title":"Lessons learned from cancer may help in the treatment of pulmonary hypertension","author":"Adnot","year":"2005","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1817-1737.134016-138","first-page":"2811","volume-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1817-1737.134016-139","first-page":"278","volume-title":"Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension","author":"Moreno-Vinasco","year":"2008","journal-title":"Physiol Genomics"},{"key":"key-10.4103\/1817-1737.134016-140","first-page":"1128","volume-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"key-10.4103\/1817-1737.134016-141","first-page":"197","volume-title":"Identifi cation of candidate genes in scleroderma-related pulmonary arterial hypertension","author":"Grigoryev","year":"2008","journal-title":"Transl Res"},{"key":"key-10.4103\/1817-1737.134016-142","first-page":"265","volume-title":"Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension","author":"Ten","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"key-10.4103\/1817-1737.134016-143","first-page":"3954","volume-title":"Lung transplantation in scleroderma compared with idiopathic pulmonary fi brosis and idiopathic pulmonary arterial hypertension","author":"Schachna","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1817-1737.134016-144","first-page":"893","volume-title":"Systemic sclerosis and bilateral lung transplantation: A single centre experience","author":"Saggar","year":"2010","journal-title":"Eur Respir J"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:19:05Z","timestamp":1786648745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1817-1737.134016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"alternative-id":["134016"],"URL":"https:\/\/doi.org\/10.4103\/1817-1737.134016","relation":{},"ISSN":["1817-1737"],"issn-type":[{"value":"1817-1737","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}